long acting glp 1 ra Berobenatide is a new investigational ultra-long-acting GLP-1 designed for MONTHLY dosing. Data was just reviewed at the ADA annual meeting. ๐๐ผ Unlike conventional GLP-1RAs, berobenatide is a fully BIASED agonist (it GLP-1-based therapies for type 2
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 15 - Aug 20


























